Bioorthogonal Masking of Circulating Antibody-TCO Groups Using Tetrazine-Functionalized Dextran Polymers.

about

Bioorthogonal Masking of Circulating Antibody-TCO Groups Using Tetrazine-Functionalized Dextran Polymers.

Item

http://www.wikidata.org/entity/Q49601103

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Bioorthogonal Masking of Circu ...... nctionalized Dextran Polymers.

@en

Bioorthogonal Masking of Circu ...... nctionalized Dextran Polymers.

@nl

type

Item

label

Bioorthogonal Masking of Circu ...... nctionalized Dextran Polymers.

@en

Bioorthogonal Masking of Circu ...... nctionalized Dextran Polymers.

@nl

prefLabel

Bioorthogonal Masking of Circu ...... nctionalized Dextran Polymers.

@en

Bioorthogonal Masking of Circu ...... nctionalized Dextran Polymers.

@nl

P1476

Bioorthogonal Masking of Circu ...... nctionalized Dextran Polymers.

@en

P2093

James Jackson

http://www.w3.org/2001/XMLSchema#string

Jason S Lewis

http://www.w3.org/2001/XMLSchema#string

Thomas R Dilling

http://www.w3.org/2001/XMLSchema#string

P2860

Tetrazine ligation: fast bioconjugation based on inverse-electron-demand Diels-Alder reactivity

Tumor vascular permeability, accumulation, and penetration of macromolecular drug carriers.

Effect of small-molecule-binding affinity on tumor uptake in vivo: a systematic study using a pretargeted bispecific antibody

Dextrans for targeted and sustained delivery of therapeutic and imaging agents.

Genetically encoded tetrazine amino acid directs rapid site-specific in vivo bioorthogonal ligation with trans-cyclooctenes.

Colonic drug delivery: prodrug approach.

Preclinical evaluation of multistep targeting of diasialoganglioside GD2 using an IgG-scFv bispecific antibody with high affinity for GD2 and DOTA metal complex

Reactive polymer enables efficient in vivo bioorthogonal chemistry.

Optimization of a Pretargeted Strategy for the PET Imaging of Colorectal Carcinoma via the Modulation of Radioligand Pharmacokinetics.

Site-specifically labeled CA19.9-targeted immunoconjugates for the PET, NIRF, and multimodal PET/NIRF imaging of pancreatic cancer.

P304

538-545

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1021/ACS.BIOCONJCHEM.8B00028

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Thomas Reiner

Kathryn M Tully

Jan-Philip Meyer

P577

2018-02-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29378403

http://www.w3.org/2001/XMLSchema#string

P932

6004324

http://www.w3.org/2001/XMLSchema#string